News/SEC filing/Feb 13, 2026, 4:07 PM ET

Amgen files annual report (10-K) for the period ended Dec 31, 2025

AmgenAMGN

Amgen filed its annual report on Form 10-K with the SEC on Feb 13, 2026, 4:07 PM ET, covering the fiscal year ended Dec 31, 2025.

  • Fiscal 2025 revenue: $36.75B
  • Fiscal 2025 net income: $7.71B
  • Fiscal 2025 diluted EPS: $14.23
  • Form 10-K accepted by EDGAR Feb 13, 2026, 4:07 PM ET
  • Accession number 0000318154-26-000010
Source
SEC EDGAR
Feb 13, 2026, 4:07 PM ET
Read the original ↗

SEC filing 10-K · accession 0000318154-26-000010 · sec.gov ↗